Bax- and Bak-induced cell death in the fission yeast Schizosaccharomyces pombe.

Por Jürgensmeier, J M, Krajewski, S, Armstrong, R C, Wilson, G M, Oltersdorf, T, Fritz, L C, Reed, J C, Ottilie, S
Publicado em 1997

Prognostic/predictive value of 207 serum factors in colorectal cancer treated with cediranib and/or chemotherapy

Por Spencer, S K M, Pommier, A J C, Morgan, S R, Barry, S T, Robertson, J D, Hoff, P M, Jürgensmeier, J M
Publicado em 2013

Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy

Por Jürgensmeier, J M, Schmoll, H-J, Robertson, J D, Brooks, L, Taboada, M, Morgan, S R, Wilson, D, Hoff, P M
Publicado em 2013

Serum protein profiling reveals baseline and pharmacodynamic biomarker signatures associated with clinical outcome in mCRC patients treated with chemotherapy ± cediranib

Por Pommier, A J C, Shaw, R, Spencer, S K M, Morgan, S R, Hoff, P M, Robertson, J D, Barry, S T, Jürgensmeier, J M
Publicado em 2014